These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22734003)

  • 1. Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion.
    Onodera Y; Nam JM; Hashimoto A; Norman JC; Shirato H; Hashimoto S; Sabe H
    J Cell Biol; 2012 Jun; 197(7):983-96. PubMed ID: 22734003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.
    Sabe H; Hashimoto S; Morishige M; Ogawa E; Hashimoto A; Nam JM; Miura K; Yano H; Onodera Y
    Traffic; 2009 Aug; 10(8):982-93. PubMed ID: 19416474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.
    Hashimoto A; Hashimoto S; Ando R; Noda K; Ogawa E; Kotani H; Hirose M; Menju T; Morishige M; Manabe T; Toda Y; Ishida S; Sabe H
    PLoS One; 2011; 6(8):e23359. PubMed ID: 21858086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
    Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
    EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.
    Hashimoto S; Hirose M; Hashimoto A; Morishige M; Yamada A; Hosaka H; Akagi K; Ogawa E; Oneyama C; Agatsuma T; Okada M; Kobayashi H; Wada H; Nakano H; Ikegami T; Nakagawa A; Sabe H
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7036-41. PubMed ID: 16636290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients.
    Sato H; Hatanaka KC; Hatanaka Y; Hatakeyama H; Hashimoto A; Matsuno Y; Fukuda S; Sabe H
    Cell Commun Signal; 2014 Mar; 12():17. PubMed ID: 24621372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer.
    Hashimoto A; Handa H; Hata S; Tsutaho A; Yoshida T; Hirano S; Hashimoto S; Sabe H
    Cell Commun Signal; 2021 May; 19(1):54. PubMed ID: 34001163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.
    Morishige M; Hashimoto S; Ogawa E; Toda Y; Kotani H; Hirose M; Wei S; Hashimoto A; Yamada A; Yano H; Mazaki Y; Kodama H; Nio Y; Manabe T; Wada H; Kobayashi H; Sabe H
    Nat Cell Biol; 2008 Jan; 10(1):85-92. PubMed ID: 18084281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.
    Haines E; Saucier C; Claing A
    J Biol Chem; 2014 Feb; 289(9):5687-703. PubMed ID: 24407288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer.
    Tsutaho A; Hashimoto A; Hashimoto S; Hata S; Kachi S; Hirano S; Sabe H
    Cell Commun Signal; 2020 Jun; 18(1):101. PubMed ID: 32580737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RCP induces Slug expression and cancer cell invasion by stabilizing β1 integrin.
    Hwang MH; Cho KH; Jeong KJ; Park YY; Kim JM; Yu SL; Park CG; Mills GB; Lee HY
    Oncogene; 2017 Feb; 36(8):1102-1111. PubMed ID: 27524413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside.
    Sabe H; Hashimoto S; Morishige M; Hashimoto A; Ogawa E
    Cell Adh Migr; 2008; 2(2):71-3. PubMed ID: 19262097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARF6 and AMAP1 are major targets of
    Hashimoto S; Furukawa S; Hashimoto A; Tsutaho A; Fukao A; Sakamura Y; Parajuli G; Onodera Y; Otsuka Y; Handa H; Oikawa T; Hata S; Nishikawa Y; Mizukami Y; Kodama Y; Murakami M; Fujiwara T; Hirano S; Sabe H
    Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17450-17459. PubMed ID: 31399545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation.
    Donnelly SK; Cabrera R; Mao SPH; Christin JR; Wu B; Guo W; Bravo-Cordero JJ; Condeelis JS; Segall JE; Hodgson L
    J Cell Biol; 2017 Dec; 216(12):4331-4349. PubMed ID: 29061650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of epithelial-mesenchymal transition by cetuximab via the EGFR-GEP100-Arf6-AMAP1 pathway in head and neck cancer.
    Matsumoto Y; Sakurai H; Kogashiwa Y; Kimura T; Matsumoto Y; Shionome T; Asano M; Saito K; Kohno N
    Head Neck; 2017 Mar; 39(3):476-485. PubMed ID: 27880014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells.
    Handa H; Hashimoto A; Hashimoto S; Sabe H
    Small GTPases; 2018 Sep; 9(5):420-426. PubMed ID: 27754741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-specific histone modification of the miR-96/182 locus targeting AMAP1 mRNA predisposes p53 to suppress cell invasion in epithelial cells.
    Handa H; Hashimoto A; Hashimoto S; Sugino H; Oikawa T; Sabe H
    Cell Commun Signal; 2018 Dec; 16(1):94. PubMed ID: 30509302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL18-dependent translocation of AMAP1 is critical for epithelial to mesenchymal transition in breast cancer.
    Li H; Zhang D; Yu J; Liu H; Chen Z; Zhong H; Wan Y
    J Cell Physiol; 2018 Apr; 233(4):3207-3217. PubMed ID: 28834540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities.
    Onodera Y; Hashimoto S; Hashimoto A; Morishige M; Mazaki Y; Yamada A; Ogawa E; Adachi M; Sakurai T; Manabe T; Wada H; Matsuura N; Sabe H
    EMBO J; 2005 Mar; 24(5):963-73. PubMed ID: 15719014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.